Strong demand and clinical progress against high-incidence diseases, calls for gene therapy manufacturers to scale up ...
The banning of a chemical in the EU has worldwide implications for biopharmaceutical manufacturing, but, thankfully, the market already offers high-performing alternatives. That was the message of a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback